Altamira Therapeutics Ltd. Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised
Altamira Therapeutics Ltd. (CYTOF) had Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised of CHF 291.68 thousand as of 2018-12-31, per its 20-F filed 2019-03-14.
Discontinued › Notes › Income Taxes
ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised · last filed 2019-03-14
- 2018-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 291.68K CHF.
- 2017-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 834.58K CHF.
- 2016-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 450.23K CHF.
| Period end | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised |
|---|---|
| 2018-12-31 | 291.68K CHF 20-F · filed 2019-03-14 |
| 2017-12-31 | 834.58K CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 450.23K CHF 20-F · filed 2018-03-22 |